Brain scans reveal how PTSD therapy rewires pleasure centers
NCT ID NCT06096740
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how a type of talk therapy called Cognitive Processing Therapy (CPT) changes brain circuits related to reward and pleasure in people with PTSD. Researchers will use brain scans to track these changes in 120 participants. The goal is to understand why some people lose the ability to feel joy after trauma and how therapy might help restore it.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cognitive Processing Therapy (CPT)
- What this could lead to
- If successful, this could reveal how therapy repairs brain reward pathways, pointing toward more effective PTSD treatments.
- What could go wrong
- This is an early-stage observational study focused on brain changes, not a treatment trial. Results may not lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
May 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * English as primary language, and comprehension suitable to understand experimenter instructions. * Current and chronic syndromic PTSD, defined as being exposed to a DSM-5 Criterion A traumatic event, with the presence DSM-5 qualifying PTSD symptoms for at least 3 months, as assessed by the Clinician-Administered PTSD Scale for DSM-5. * Able and willing to undergo functional magnetic resonance imaging (fMRI). * Willingness to participate in repeated assessments and as part of a delayed treatment group. Exclusion Criteria: * Evidence of current or prior history of psychosis or bipolar disorder as evidenced by self-report or clinical interview. * Active substance dependence within the past 6 months as evidenced by clinical interview. * Current regular psychiatric medication use (i.e. antidepressants), except for as-needed benzodiazepine or opiate medication no more than three times per week, on average, or for short-duration stimulant medication for attention deficit hyperactivity disorder that can be skipped within 24 hours of study visits. * A recent (\<6 months) suicide attempt or current active ideation with intent. * Unremovable ferrous metal in body. * History of neurological disorder, stroke, seizures/convulsions (except febrile seizures in childhood), epilepsy, brain surgery, electroconvulsive or radiation treatment, brain hemorrhage or tumor, or thyroid disorder. * Anyone who is pregnant or trying to become pregnant. * Current or past year (\> 3 sessions), psychotherapy with a prominent exposure or cognitive restructuring component. * Previous or current (es)ketamine treatment and/ or brain stimulation/neuromodulation treatment. * Other ongoing treatment that is likely to confound experimental effects. * Previous penetrating head injury/traumatic brain injury. Mild-to-moderate traumatic brain injury without penetrating injury is allowable.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anhedonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600
RECRUITINGAustin, Texas, 78712, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five sessions to quiet trauma nightmares in bipolar disorder
- Can training teens to recall good moments lift their mood?
- Can training hospital staff in Trauma-Informed care make childbirth safer?
- Scientists probe brain's reward system in mental illness
- Can a mindfulness class help veterans with concussion and PTSD?
- Can MDMA plus therapy help veterans fight both PTSD and alcohol addiction?